TCMBANKIN004933 |
Palustrine |
palustrine; C10608; (13S,17S)-17-[(1S)-1-hydroxypropyl]-1,5,10-triazabicyclo[11.4.0]heptadec-14-en-11-one; AC1NB0HZ; 17-(1-hydroxypropyl)-1,5,10-triazabicyclo[11.4.0]heptadec-14-en-11-one; 22324-44-3 |
C17H31N3O2 |
309.45 |
CCC(C1CC=CC2N1CCCNCCCCNC(=O)C2)O |
TCMBANKIN005978 |
kaempferol-3-rutinoside |
kaempferol3-rutinoside |
C27H30O15 |
594.5 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O)O)O |
TCMBANKIN012544 |
kaempferol-3-rhamnosyl glucoside-7-glucoside |
|
C33H40O20 |
|
CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3=C(OC4=CC(=CC(=C4C3=O)O)OC5C(C(C(C(O5)CO)O)O)O)C6=CC=C(C=C6)O)CO)O)O)O |
TCMBANKIN022078 |
trans-aconitic acid |
trans-aconiticacid |
C6H6O6 |
174.11 g/mol |
C(C(=CC(=O)O)C(=O)O)C(=O)O |
TCMBANKIN033434 |
palustridine |
|
C18H31N3O3 |
|
CCC(C1C=CCC2N1CCCN(CCCCNC(=O)C2)C=O)O |
TCMBANKIN057920 |
(Z)- aconitic acid |
cis-aconitic acid;cis-1-propene-1,2,3-tricarboxylic acid; ST5308041; cis-Propene-1,2,3-tricarboxylic acid; (1Z)-prop-1-ene-1,2,3-tricarboxylic acid; Propene-1,2,3-tricarboxylic acid; 1-Propene-1,2,3-tricarboxylic acid, (Z)- (8CI)(9CI); 3-Carboxy-2-pentenedioic acid; (Z)-1-Propene-1,2,3-tricarboxylic acid; NSC 7616; 1,2,3-Propenetricarboxylic acid; CHEBI:32805; A3412_SIGMA; 1,2,3-PROPENETRICARBOXYLIC ACID,(TRANS); CCRIS 2507; HSDB 635; AI3-14615; 01590_FLUKA; EINECS 207-877-0; EINECS 209-564-4; (Z)-prop-1-ene-1,2,3-tricarboxylic acid; 3-Carboxyglutaconic acid; NSC 227901; NCI7616; InChI=1/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1; FEMA No. 2010; C00417; 1-Propene-1,2,3-tricarboxylic acid, (1Z)-;ACONITATE, CIS |
C6H6O6 |
174.11 g/mol |
C(C(=CC(=O)O)C(=O)O)C(=O)O |
TCMBANKIN058218 |
KaemPferol-3 |
kaempferol-3,7-diglucoside; 7-O-diglucoside |
C27H30O16 |
610.52 |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O |
TCMBANKIN060166 |
kaempferol-7-O-rhamnoside |
|
C21H20O10 |
432.38 |
CC1C(C(C(C(O1)OC2=CC(=C3C(=C2)OC(=C(C3=O)O)C4=CC=C(C=C4)O)O)O)O)O |
TCMBANKIN060267 |
quercetin-3,7-rutinosogalactoside |
|
C33H40O21 |
772.7 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)OC5C(C(C(C(O5)CO)O)O)O)C6=CC(=C(C=C6)O)O)O)O)O)O)O)O |
TCMBANKIN061371 |
nicotine |
36733_RIEDEL; 2yk1; CHEBI:59806; 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine; (2S)-1-methyl-2-(pyridin-3-yl)pyrrolidinium; (S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE; D03365; 54-11-5; NCGC00090693-03; 46343_RIEDEL; C00745; Nicotine; NCGC00090693-04; AIDS-156031; 65-31-6 (R,R-BITARTRATE); (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine; (S)-3-(N-methylpyrrolidin-2-yl)pyridine; Habitrol (TN); SBB012359; N5511_SIGMA; (−)-Nicotine; Nicotine (compounds related to); PDSP2_000555; NCT; N3876_SIGMA; 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine; NCGC00090693-01; ZB012057; (S)-(-)-nicotine; CHEBI:17688; SDCCGMLS-0066911.P001; (S)-nicotinium(1+); AC1OCG5J; 3-(2-(N-methylpyrrolidinyl))pyridine; NSC97238 (R,R-BITARTRATE SALT); 3-[(2S)-1-methylpyrrolidin-1-ium-2-yl]pyridine; (S)-nicotinium cation; AIDS156031; NCGC00090693-05; PDSP1_000465; PDSP1_000113; PDSP2_000463; (S)-3-(1-methylpyrrolidin-2-yl)pyridine; Nicotine (USP); 54-11-5 (FREE BASE); L(-)-nicotine; (−)-Nicotine solution |
C10H14N2 |
162.23 g/mol |
CN1CCCC1C2=CN=CC=C2 |